Ketamine Dose for Depression: A Guide to Transformative Therapy 

Get Started
Ketamine dose for depression

Ketamine has emerged as a groundbreaking solution for individuals battling treatment-resistant depression (TRD). Approved by the FDA for this purpose, the Ketamine treatment offers hope when traditional antidepressants and therapy fail to provide relief. Delivered in controlled doses, this innovative treatment is reshaping the mental health landscape, combining rapid efficacy with a well-established safety profile. 

What is the Ketamine dose for depression, how does Spravato help with depression, is it safe, are there any adverse effects, and how is intranasal Esketamine different intravenous Ketamine from all these points of view?

Keep reading if you want to learn more about this new treatment of depression and its dosage.

Key Takeaways

  • Ketamine therapy has shown significant promise in treating depression, particularly for individuals who have not responded to traditional antidepressants. 
  • The effectiveness of the Ketamine treatment is linked to its ability to rapidly impact neurotransmitter systems, leading to a quicker alleviation of depressive symptoms compared to conventional treatments. 
  • Dosage and administration should be carefully monitored under medical supervision, as the therapeutic use of ketamine requires precision and safety protocols. 

What is Ketamine Therapy? 

Ketamine therapy involves the use of ketamine, a medication historically used as an anesthetic, repurposed for mental health treatment (particularly for depressed patients who have tried conventional depression treatments before, but have not seen a relief of symptoms).

Unlike conventional antidepressants, which may take weeks to show results, Ketamine works rapidly (sometimes even within hours or days). 

This medication is considered an NMDA antagonist–it works by blocking the NMDA (N-methyl-D-aspartate) receptors in the brain. Because these receptors play a role in mood regulation and synaptic connections, Ketamine is uniquely effective for treatment-resistant depression (TRD). 

This therapy is not a “one-size-fits-all” approach (as no therapy connected to mental health ever should be). Yet, across the board, Ketamine patients often describe ketamine as providing a sense of clarity or lightness. By restoring hope and reducing debilitating symptoms, Ketamine allows individuals who suffer from severe depression to reconnect with their lives and selves. 

Unique Benefits of Ketamine Therapy 

There is a reason Ketamine therapy is gaining popularity in the field of psychopharmacology. Various outcomes in patients receiving Ketamine treatment have been noticed:

  • Rapid relief: Patients may notice significant mood improvement after just one session.
  • Efficacy in resistant cases: It’s often effective when other treatments have been exhausted.
  • Restorative effects: Ketamine promotes new neural connections, potentially reversing some of the damage caused by prolonged depression. 
  • Accessibility: Marpa Minds ensures treatments are insurance-covered, removing financial hurdles for patients.

Wondering if Ketamine therapy could work for you? Read more on our blog: 

Understanding Ketamine Dosing 

Achieving positive outcomes with Ketamine therapy starts with the correct dose. The dose of Ketamine is generally subanesthetic, tailored to each patient. 

Here are the essentials you may want to know about the dose of Ketamine usually administered to patients with depression.

Dosage Range 

As mentioned before, Ketamine therapy is not a one-size-fits-all, and that is as much about results as it is about administration. As a general rule, however, here’s what you need to know about dose of Ketamine: 

  • The typical range is 0.1 mg/kg to 0.75 mg/kg. 
  • Most patients begin with 0.5 mg/kg, a dose widely studied for its safety and efficacy. 
  • Some patients may require lower dosing for safety, while others may need slightly higher doses to achieve a therapeutic response. Factors like body weight, overall health, and treatment goals heavily influence dosing plans. 

At Marpa Minds, our clinicians provide full Ketamine titration, optimizing doses for the best results and ensuring both efficacy and patient comfort.

We recognize that depression impacts every individual differently, and personalization is key to producing effective and lasting change. This is not just about the medication–it’s about the way we help our patients navigate questions, customize the treatment and dosing to their needs, and follow through to support a quick recovery. 

Common Methods for Administering Ketamine for Depression

Ketamine treatment can be administered via various routes, and this will influence the dosing as well. There are four main types of routes Ketamine patients can choose from, each with its dose recommendations, titration, specific effects, and level of FDA approval.

  1. Intravenous (IV). This type of administration is effective because intravenous Ketamine is delivered directly into the bloodstream, allowing for rapid results. A typical IV session lasts about 40 minutes.
  2. Intranasal (Spravato). Spravato (intranasal Esketamine) is an FDA-approved option specifically designed for treatment-resistant depression. It is a convenient method, as it can be self-administered under professional guidance. Unlike racemic ketamine, esketamine is a more potent isomer that is specifically FDA-approved for treatment-resistant depression.
  3. Subcutaneous or Intramuscular (Injection). Subcutaneous and intramuscular injections are safe and practical alternatives to other methods, because administration through these methods minimizes the overall session time.
  4. Oral administration or Sublingual. Oral or sublingual administration is an easy and accessible option for long-term maintenance. However, it is worth noting that the oral route has lower bioavailability compared to other approaches.

Safety and Efficacy 

Ketamine’s safety profile is well-documented, though treatments should only be administered in clinical settings under professional supervision. Still, due to the immediate effects of Ketamine treatment, we recommend that patients arrange for someone to accompany them home, as it is not safe to drive following the session.

There are minimal side effects associated with this treatment, and any common effects (such as mild dissociation), are typically temporary. These symptoms are carefully monitored by specialists to ensure patient safety and comfort throughout the process.

There is no long-term risk of addiction when the treatment is administered in controlled and supervised doses. The structured approach and professional oversight ensure that the medication is used responsibly and effectively, avoiding any potential for dependency.

Comprehensive monitoring is a key component of the treatment to provide a safe and supportive experience, and one of the main reasons Spravato cannot be administered at home. From the initial doses to ongoing maintenance sessions and individualized dose up-titration, every stage is closely observed by trained professionals to ensure the best possible outcomes for patients.

Clinical Evidence for the Efficiency of Esketamine

Multiple researchers have shown findings that Esketamine (Spravato) is a powerful, quick-acting intervention for treatment-resistent depression. Moreover, findings have also pointed out to the safety of this treatment as well.

For example, in Phase 4 double-blind, placebo-controlled clinical trial with 378 adults with treatment-resistant depression found that Esketamine nasal spray (56mg or 84mg) significantly improved depressive symptoms compared to placebo, with effects seen within 24 hours and sustained over 28 days. Response and remission rates were 2-3 times higher for esketamine, showcasing its rapid and robust antidepressant efficacy.

On the efficacy of esketamine, another study found that long-term treatment with esketamine nasal spray, intermittently combined with an oral antidepressant, led to sustained improvements in depressive symptoms over 4.5 years. In this open-label extension study with 1,148 adults, remission rates reached nearly 50% at long-term follow-up, with most participants maintaining their progress and low discontinuation rates due to adverse effects or lack of efficacy

Why Ketamine Works for Depression

Ketamine is more than a mood lifter; its effects extend to neuroplasticity, enhancing the brain’s ability to adapt and recover from chronic depression. Unlike some other treatments, Ketamine addresses both the emotional and biological components of depression. 

At Marpa Minds, we prioritize safety and transparency. Ketamine treatment plans are carefully considered and clearly communicated, including expected outcomes and possible side effects, so patients feel truly supported throughout their healing process. 

Learn more: how long does Ketamine nasal spray last?

Why Choose Marpa Minds? 

Marpa Minds isn’t just a clinic—it’s a sanctuary for healing. 

We understand the weight of finding a treatment for depression that works for you. As such we aim to be a knowledgeable, compassionate guide for patients seeking freedom from its burdens. 

When you walk into our clinic, expect to be met with:

A Serene Environment

Our spa-like atmosphere promotes relaxation and peace, fostering mental and emotional restoration. Soft lighting, calming scents, and tranquil music work together to create a space where patients can feel truly at ease.

Clinical Expertise

Our licensed professionals specialize in ketamine therapy, ensuring precision and patient-first care. With a commitment to ongoing education and innovation, our team stays at the forefront of treatment advancements for the best outcomes.

Comprehensive Care Coordination

From insurance approvals to tailored treatment plans, we handle the logistics, so patients can focus on recovery. Our team ensures seamless communication between providers and patients, making the entire process stress-free.

Inclusive Approach

Every patient is welcomed with dignity, regardless of background, ensuring diverse individuals feel understood and supported. We celebrate individuality and work to create a space where everyone feels safe to begin their healing journey.

Holistic Support

Beyond the therapy room, we aim to create a positive experience for our patients. Our services are not just about the Ketamine treatment gains: our goal is to destigmatize seeking help and empower patients to regain control of their lives.

At Marpa Minds, hope is more than an idea—it’s something we deliver daily through clear communication, specialized treatments, and empathy. 

For those navigating the weight of treatment-resistant depression, Ketamine therapy and Spravato specifically, have been proven to have an excellent success rate, offering an extraordinary opportunity for relief (sometimes even within minutes of administration). Its benefits—quick results, safety, and effectiveness—are deeply reassuring for individuals who’ve experienced limited success with traditional treatments. 

At Marpa Minds, we’ve designed every element of our service to ensure patients feel cared for, understood, and hopeful. If you’re exhausted by treatment-resistant depression and seeking solutions that work, we’re here to guide you on your path to healing. 

Contact us and allow us to help you find your way to a better, healthier life. 

About Author

Amy Della Rocca

PMHNP – Clinical Director
Meet Amy Della Rocca, a Psychiatric Nurse Practitioner with experience in innovative mental health treatments. Amy’s credentials hail from Columbia University and her previous work experience is in Behavioral Health, Public health and Primary Care Medicine. Amy’s unwavering belief in the potential of ketamine treatment for mental well-being stems from hands-on experience with her patients. Witnessing its positive impact and lasting changes drove her to specialize in this unique field. What sets Amy apart is her holistic approach. She considers medical, emotional, and psychological aspects, earning respect for her practical solutions. Operating from Marpa, Amy evaluates patients for Spravato compatibility. She provides comprehensive on-site care during their Spravato treatment journey. Amy supports patients from evaluation to treatment completion and collaborates with their existing mental and physical health care team. Amy’s contribution goes beyond caregiving; she actively advances Ketamine Therapy. Her expertise and dedication have garnered trust among colleagues and patients alike.